Validation of daily 0.35 T diffusion-weighted MRI for MRI-guided glioblastoma radiotherapy.
Natalia LutsikSiamak P Nejad-DavaraniAlessandro ValderramaJanette HerrDanilo MazieroKaylie CullisonGregory A AzzamGregory J KubicekJessica MeshmanMacarena I de la FuenteTess ArmstrongEric A MellonPublished in: Medical physics (2024)
EPI-DWI on a 0.35 T MRI-Linac showed superior image quality compared with TSE-DWI, minor and less distortions than high-field diagnostic scanners, and comparable ADC values in phantoms and glioblastoma tumors. EPI-DWI should be investigated on the 0.35 T MRI-Linac for prediction of early response in patients with glioblastoma.